Rheumatology Advance Access published online on February 16, 2005
Rheumatology, doi:10.1093/rheumatology/keh574
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Rheumatology Unit, Institute of Child Health, University College London and Great Ormond Street Hospital, UK
* To whom correspondence should be addressed.
Editorial
Paediatric rheumatology: a bright future in the UK and Europe
2 Institute of Child Health and The Windeyer Institute of Medical Sciences, University College London, UK
3 Queen Alexandra Hospital, Portsmouth, UK
L. R. Wedderburn, E-mail: l.wedderburn{at}ich.ucl.ac.uk
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
L. J. Kay, I. D. Griffiths, and for the BSR Biologics Register Management committe UK consultant rheumatologists' access to biological agents and views on the BSR Biologics Register Rheumatology, November 1, 2006; 45(11): 1376 - 1379. [Abstract] [Full Text] [PDF] |
||||
